AbbVie's Psoriasis Drug Approved For Japan, But The Main Event Is Yet To ComeSeeking Alpha • 04/11/19
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug ApprovalsZacks Investment Research • 03/29/19
AbbVie stock down 0.8% after FDA places hold on clinical trials of venetoclax as a treatment for multiple myelomaMarket Watch • 03/19/19